The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

37 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
29
1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2.EBI
University of Kentucky
13
Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.EBI
University of Arkansas For Medical Sciences
6
Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.EBI
University of Kentucky
9
Synthesis and evaluation of novel azetidine analogs as potent inhibitors of vesicular [3H]dopamine uptake.EBI
University of Kentucky
10
Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).EBI
University of Arkansas For Medical Sciences
27
Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.EBI
University of Kentucky
20
Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).EBI
University of Kentucky
34
Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives: a structure-activity study.EBI
Wichita State University
28
Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.EBI
University of Kentucky
8
Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.EBI
University of Pennsylvania
11
Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors.EBI
China Pharmaceutical University
6
Quinlobelane: a water-soluble lobelane analogue and inhibitor of VMAT2.EBI
University of Kentucky
6
Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2.EBI
Key Laboratory of Radiopharmaceuticals (Beijing Normal University)
20
Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2.EBI
University of Kentucky
21
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors.EBI
Novartis Biomedical Research
10
Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.EBI
University of Kentucky
11
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies.EBI
Novartis Institutes For Biomedical Research
2
Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.EBI
Columbia University College of Physicians and Surgeons
12
Ibogaine and Their Analogs as Therapeutics for Neurological and Psychiatric Disorders.EBI
Usona Institute
13
Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.EBI
University of Kentucky
25
Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitors.EBI
Yantai University
16
Characterization of a series of 3-amino-2-phenylpropene derivatives as novel bovine chromaffin vesicular monoamine transporter inhibitors.EBI
Wichita State University
3
Biotransformation: Impact and Application of Metabolism in Drug Discovery.EBI
Hypha Discovery
23
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.EBI
Novartis Institutes For Biomedical Research
12
Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2.EBI
University of Kentucky
11
The Druggability of Solute Carriers.EBI
The Scripps Research Institute
7
In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.EBI
University of Michigan Medical School
38
Exploring the effect of EBI
University of Arkansas For Medical Sciences
21
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.EBI
Organix
18
Fluoroethoxy-1,4-diphenethylpiperidine and piperazine derivatives: Potent and selective inhibitors of [EBI
University of Kentucky
40
Immunophilin binding agents and uses thereofBDB
University of California
8
ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOGBDB
Shanghai Institute of Materia Medica
20
TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOFBDB
Medshine Discovery
5
Bismuth(III) compounds and methods thereofBDB
The University of Hong Kong
47
Heterocyclic compounds and uses thereofBDB
Celgene Car
101
Carboxamide-pyrimidine derivatives as SHP2 antagonistsBDB
Merck Patent
6
Bryostatin analogues, synthetic methods and usesBDB
The Leland Stanford Junior University